Hanan Nassar

Topoisomerase II α Gene alteration in Triple Negative Breast Cancer and Its Predictive Role for Anthracycline-Based Chemotherapy (Egyptian NCI Patients)

Mahitab Ibrahim Eltohamy, Omnia M. Badawy, Naglaa El kinaai et al. · Asian Pacific Journal of Cancer Prevention · 2018 · 17 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Capecitabine-Based Chemoendocrine Combination as First-Line Treatment for Metastatic Hormone-Positive Metastatic Breast Cancer: Phase 2 Study

Noha Rashad, Thoraya Abdelhamid, Samia A. Shouman et al. · Clinical Breast Cancer · 2020 · 16 citations

Medicine, Oncology, Pharmacology +17

Impact of FLT3 Receptor (CD135) Detection by Flow Cytometry on Clinical Outcome of Adult Acute Myeloid Leukemia Patients

Eman Z. Kandeel, G. El Sayed, Nahla El-Sharkawy et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 15 citations

Medicine, Hematology, Oncology +15

First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study

Mostafa El-Serafi, Ahmed A. Zeeneldin, Ibrahim M. Abdelsalam et al. · Journal of the Egyptian National Cancer Institute · 2018 · 14 citations · Full text

Medicine, Oncology, Pharmacology +14

Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients

Ghada M. El‐Sayed, Hanan Nassar, Amr Zaher et al. · Journal of the Egyptian National Cancer Institute · 2013 · 11 citations · Full text

Medicine, Hematology, Molecular Genetics +16